232 related articles for article (PubMed ID: 12297913)
1. Outcome of histologically node-negative esophageal squamous cell carcinoma.
Tabira Y; Yasunaga M; Sakaguchi T; Yamaguchi Y; Okuma T; Kawasuji M
World J Surg; 2002 Dec; 26(12):1446-51. PubMed ID: 12297913
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Ota M; Takasaki K
J Surg Oncol; 2002 Apr; 79(4):224-9. PubMed ID: 11920779
[TBL] [Abstract][Full Text] [Related]
3. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in node-negative squamous cell carcinoma of the thoracic esophagus.
Tachibana M; Kinugasa S; Dhar DK; Shibakita M; Ohno S; Masunaga R; Kotoh T; Kubota H; Nagasue N
Int J Surg Investig; 2000; 1(5):389-95. PubMed ID: 11341595
[TBL] [Abstract][Full Text] [Related]
5. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.
Kosuga T; Shiozaki A; Fujiwara H; Ichikawa D; Okamoto K; Komatsu S; Otsuji E
World J Surg; 2011 Apr; 35(4):798-804. PubMed ID: 21312037
[TBL] [Abstract][Full Text] [Related]
7. Significance of lymph node capsular invasion in esophageal squamous cell carcinoma.
Sakai M; Suzuki S; Sano A; Tanaka N; Inose T; Sohda M; Nakajima M; Miyazaki T; Kuwano H
Ann Surg Oncol; 2012 Jun; 19(6):1911-7. PubMed ID: 22290569
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus.
Tachibana M; Kinugasa S; Dhar DK; Tabara H; Masunaga R; Kotoh T; Kubota H; Nagasue N
Arch Surg; 1999 Jan; 134(1):50-4. PubMed ID: 9927130
[TBL] [Abstract][Full Text] [Related]
9. Analysis of micrometastatic disease in histologically negative lymph nodes of patients with adenocarcinoma of the distal esophagus or gastric cardia.
Buskens CJ; Ten Kate FJ; Obertop H; Izbicki JR; van Lanschot JJ
Dis Esophagus; 2008; 21(6):488-95. PubMed ID: 18840133
[TBL] [Abstract][Full Text] [Related]
10. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
[TBL] [Abstract][Full Text] [Related]
11. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
[TBL] [Abstract][Full Text] [Related]
12. Outcome and treatment strategy for mid- and lower-thoracic esophageal cancer recurring locally in the lymph nodes of the neck.
Motoyama S; Kitamura M; Saito R; Maruyama K; Okuyama M; Ogawa J
World J Surg; 2006 Feb; 30(2):191-8. PubMed ID: 16425071
[TBL] [Abstract][Full Text] [Related]
13. Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Sun ZG; Liu XY; Zhang M; Wang Z
Hepatogastroenterology; 2014 May; 61(131):671-7. PubMed ID: 26176055
[TBL] [Abstract][Full Text] [Related]
14. The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas.
Wenzel S; Sagowski C; Kehrl W; Metternich FU
Eur Arch Otorhinolaryngol; 2004 May; 261(5):270-5. PubMed ID: 14504863
[TBL] [Abstract][Full Text] [Related]
15. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?
Shim YM; Park JS; Lee M; Kim D; Kim K
Dis Esophagus; 2013 Apr; 26(3):272-5. PubMed ID: 22642487
[TBL] [Abstract][Full Text] [Related]
16. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection.
Hsu PK; Huang CS; Wang BY; Wu YC; Chou TY; Hsu WH
Ann Thorac Surg; 2013 Sep; 96(3):995-1001. PubMed ID: 23866797
[TBL] [Abstract][Full Text] [Related]
18. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.
Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713
[TBL] [Abstract][Full Text] [Related]
19. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma.
Sato F; Shimada Y; Li Z; Watanabe G; Maeda M; Imamura M
Br J Surg; 2001 Mar; 88(3):426-32. PubMed ID: 11260111
[TBL] [Abstract][Full Text] [Related]
20. Esophageal cancer with distant lymph node metastasis: prognostic significance of metastatic lymph node ratio.
Tachibana M; Dhar DK; Kinugasa S; Kotoh T; Shibakita M; Ohno S; Masunaga R; Kubota H; Nagasue N
J Clin Gastroenterol; 2000 Dec; 31(4):318-22. PubMed ID: 11129274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
